Serum IL-6 level and the development of disability in older persons

Journal of the American Geriatrics Society

Volumn 47, Issue 6, 1999, Pages 639-646

  Ferrucci, Luigi ^a,b   Harris, Tamara B ^b   Guralnik, Jack M ^b   Tracy, Russell P ^c   Corti, Maria Chiara ^b,d   Cohen, Harvey J ^e   Penninx, Brenda ^b   Pahor, Marco ^f   Wallace, Robert ^g   Havlik, Richard J ^b  

^a INRCA   (Italy)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g UNIVERSITY OF IOWA   (United States)

Author keywords

Aging; Disability; IL 6; Inflammation

Indexed keywords

ALBUMIN; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CYTOKINE; FIBRINOGEN; HAPTOGLOBIN; INTERLEUKIN 6;

AGING; ARTICLE; DAILY LIFE ACTIVITY; DISABILITY; FOLLOW UP; IMMUNE RESPONSE; INFLAMMATION; PATHOPHYSIOLOGY; PREDICTION; RISK FACTOR;

EID: 0033024330     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb01583.x     Document Type: Article

References (46)

1. Guralnik JM. Understanding the relationship between disease and disability. J Am Geriatr Soc 1994;42:1128-1129.
2. Evans JW. What is sarcopenia. J Gerontol 1995;50A:5-8.
3. Buchner DM, Wagner EH. Preventing frail health. Clinics Geriatr Med 1992;8:1-17.
4. Sobel E, Louhija J, Sulkava R et al.. Lack of association of apolipoprotein E allele epsilon4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-907.
5. Corti MC, Guralnik JM, Salive ME et al. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997;126:753-759.
6. Curb JD, Abbott RD, MacLean CL et al. Age-related changes in stroke risk in men with hypertension and normal blood pressure. Stroke 1996;27:819-824.
7. Corti MC, Guralnik JM, Bilato C. Coronary heart disease risk factors in older persons. Aging Clin Exp Res 1996;8:75-89.
8. Ershler WB, Sun WH, Binkley N. The role of interleukin-6 in certain age-related diseases. Drugs Aging 1994;5:358-365.
9. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15: 74-80.
10. Hager K, Machein U, Krieger S et al. Interleukin 6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging 1994;771-772.
11. Hirose N, Aral Y, Kawamura M et al. Tokio Centenarian Study. 5. Nutritional status of Japanese centenarians. Nippon Ronen lgakkai Zasshi 1997; 34:324-330.
12. Haverkate F, Thompson SG, Pyke SDM et al. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 1997; 349:462-466.
13. Ridker PM, Cushman M, Stampfer MJ et al. Inflammation, aspirin, and the risk of cardiovascular diseases in apparently healthy men. N Engl J Med 1997;336:973-979.
14. Biasucci LM, Vitelli A, Liuzzo G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:847-877.
15. Liuzzo G, Biasucci LM, Gallimore JM et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-424.
16. Tracy RP, Lemaitre RN, Psaty BM et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-1127.
17. Sasayama S, Matsumori A, Matoba Y et al. Immunomodulation: A new horizon for medical treatment of heart failure. J Cardiac Failure 1996;2:S287-294.
18. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 1996;11:1043-1051.
19. Moreland LW, Baumgartner SW, Schiff MH et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-147.
20. Sipe DJ. Acute-phase proteins in osteoarthritis. Semin Arthritis Rheum 1995; 25:75-86.
21. Sluzwska A, Rybakowski J, Bosmans E et al. Indicators of immune activation in major depression. Psychiatry Res 1996;64:161-167.
22. Hull M, Fiebich BL, Berger M et al. Interleukin-6 associated inflammatory process in Alzheimer's disease: new therapeutic options. Neurobiol Aging 1996;795-800.
23. Moldawer LL, Copeland EM. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interaction and therapeutic options. Cancer 1997;79:1828-1839.
24. Mitch WE, Goldberg AL. Mechanism of muscle wasting. The role of Ubiquitin-Proteasome pathway. N Engl J Med 1997;335:1897-1905.
25. Cohen HJ, Pieper CF, Harris T et al. Plasma IL-6: An indicator of functional disability in community dwelling elderly. J Gerontolol Med Sci 1997;52: M201-208.
26. Cornoni-Huntley J, Ostfeld AM, Taylor JO et al. Established populations for epidemiologic studies of the elderly: Study design and methodology. Aging Clin Exp Res 1993;5:27-37.
27. Rosow I, Breslau N. A Guttman health scale for the aged. J Gerontol 1966; 21:556-559.
28. Katz S, Stroud III MW. Functional assessment in geriatrics. A review of progress and directions. J Am Geriatr Soc 1989;37:267-271.
29. Rao KMK, Pieper CS, Currie MS, Cohen HJ. Variability of Plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol 1994;102:802-805.
30. Pfeiffer E. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Am Geriatr Soc 1975;23:433-441.
31. Hypertension Detection and Follow-up Program Cooperative Group. Blood pressure studies in 14 communities: A two stage screen for hypertension. JAMA 1977;237:2385-2391.
32. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Second report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;29:1329-1445.
33. Prentice RL. On the design of synthetic case control studies. Biometrics 1986;42:301-310.
34. Hastie TJ, Tibshirani RJ. Generalized additive models. London: Chapman & Hall, 1994.
35. Mantel N. Synthetic retrospective studies and related topics. Biometrics 1973;29:479-486.
36. Roubenoff R. Inflammatory and hormonal mediators of cachexia. J Nutr 1997;127:1014-1016.
37. Navab M, Berliner JA, Watson AD et al. The yin and the yang of oxidation in the development of the fatty streak. Arterioscler Thromb Vasc Biol 1996; 16:831-842.
38. Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link? Lancet 1997;349:1391-1392.
39. Van der Wal AC, Becker AE, Van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36-44.
40. Jilka RL, Hangoc G, Girasole G et al. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992;257:88-91.
41. Badolato R, Oppenheim JJ. Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 1996;26:526-538.
42. Corti MC, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994; 272:1036-1042.
43. Corti MC, Guralnik JM, Salive ME et al. Serum iron level, coronary artery disease, and all-cause mortality in older men and women. Am J Cardiol 1997;79:1-7.
44. Tracy RP, Psaty BM, Bovill EG et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 1997; 17:2167-2176.
45. Hotamisligil GS, Arner P, Caro JF et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415.
46. Le JM, Vilcek J. Interleukin 6: A multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989;61: 588-602.